DHPA

  • Home
  • About Us
    • Leadership
      • Executive Committee
      • Board Members
    • DHPA Members
    • Contact Us
    • Join Us
  • Advocacy
    • Patient Access to Independent GI Care
      • Colorectal Cancer Screening
    • Diversity Equity and Inclusion
    • Modernizing the Stark Law
    • Saving the IOASE
    • Pathology Services Utilization
  • Resources
    • CRC Screening
    • Independent GI Careers
    • Research
    • Fact Sheets
    • Letters to Policymakers
    • Leadership Series
  • Newsroom
    • Press Releases
    • DHPA in the News
    • GI News Round Up
  • Take Action

September 13, 2023

DHPA Supports the Protecting Patient Access to Cancer and Complex Therapies Act

The Digestive Health Physicians Association today announced its support of the Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764, H.R. 5391) introduced by U.S. Senator John Barrasso (R-WY), U.S. Representative Mike Burgess (R-TX) and U.S. Representative Greg Murphy (R-NC).

A provision in the Inflation Reduction Act of 2022 cuts reimbursement for certain Part B drugs from Average Sales Price plus six percent to the Maximum Fair Price (MFP) that is negotiated by the Centers for Medicare & Medicaid Services (CMS). According to the Congressional Budget Office, reimbursement for Part B drugs (and the associated add-on payment) will be cut by an estimated 50 percent or more for those drugs that are subject to negotiation.

“An unintended consequence of the Inflation Reduction Act was that reimbursements to physicians were cut significantly, making it difficult to provide certain medications that our patients with chronic illnesses desperately need,” said Dr. Scott Ketover, president and board chair of DHPA. “This policy could jeopardize the viability of medical practices, especially smaller groups, and those in rural or underserved areas. If we are no longer able to afford to administer these drugs, our patients will be forced to get their medications in the more expensive hospital setting.”

The Protecting Patient Access to Cancer and Complex Therapies Act is budget neutral and would maintain current reimbursements to providers, while saving Medicare the same amount of money by replacing the ASP payment cut for Part B drugs with a manufacturer rebate. Patient’s coinsurance would be based off the lower, rebated price (the MFP) and the manufacturer rebate would account for the coinsurance reduction.

“The Protecting Patient Access to Cancer and Complex Therapies Act protects our ability to provide these complex therapies in our practices, while still achieving the same savings for the Medicare program,” said Dr. Ketover. “We hope Congress can advance this bill without delay.”

Rebates, such as the Medicaid Drug Rebate Program and inflation rebates in Medicare, are a common cost-savings tool used by the government and private payers and would not cause disruption to providers and beneficiaries.

###

Filed Under: Advocacy, Newsroom, Press Releases, Protecting Patient Access to Integrated GI Care in the Independent Setting

Member Spotlight

Allied Digestive Health is a gastroenterology and hepatology practice with more than 50 locations throughout New Jersey and New York, specializing in colon cancer screening, and the treatment of Celiac Disease, GERD, and IBD.

Learn more at:
www.allieddigestivehealth.com

Become a Member

    Is your practice interested in promoting and preserving accessible, high quality and cost-efficient care in the independent GI medical setting? Contact us today about joining DHPA.

    Recent News

    • DHPA Supports the Protecting Patient Access to Cancer and Complex Therapies Act

    • DHPA Supports Guidelines that Recommend Colorectal Cancer Screening Starting at Age 45

    • Video: Establishing a Formal Mentorship Program in an Independent GI Practice

    • UnitedHealthcare’s Advance Notification Policy: Paperwork Over Patient Care

    • Statement on UnitedHealthcare’s Advance Notification Policy for Gastroenterology Services

    • Colorectal Cancer: Am I at Risk? Spanish Translation (Video)

    • The Value of Colonoscopy: The Gold Standard in Colorectal Cancer Screening (Video)

    • Colorectal Cancer: Am I at Risk? (Video)

    • The Value of Colonoscopy (Infographic)

    Digestive Health Physicians Association, Inc.
    10770 Columbia Pike, Suite 400
    Silver Spring, Maryland, 20901
    © 2020 DHPA

    Follow @DHPAnews
    Tweets by DHPAnews

    Copyright © 2023 · Executive Pro Theme on Genesis Framework · WordPress · Log in